Platelet-activating factor is a general membrane perturbant.

Biochimica Et Biophysica Acta
D B Sawyer, O S Andersen

Abstract

Platelet-activating factor (PAF) is, at physiological (nanomolar) concentrations, a potent mediator of inflammation and coagulation. At pharmacological (micromolar) concentrations, PAF induces a variety of effects in diverse tissues. Here we show that PAF at micromolar concentrations is a membrane perturbant. Micromolar PAF alters the properties of channels formed by gramicidin A, and at concentrations greater than or equal to 4 microM disrupts the barrier properties of the host lipid bilayer. PAF thus can act as a detergent and non-specifically alter the behavior of membranes and membrane proteins. This may provide an explanation for some of the effects of PAF seen at high concentrations in vitro.

References

Nov 1, 1977·Archives of Biochemistry and Biophysics·P Schlieper, E De Robertis
Aug 8, 1989·Biochemistry·D B SawyerO S Andersen
Jan 1, 1984·Annual Review of Physiology·O S Andersen
Apr 25, 1983·Life Sciences·Z TerashitaK Nishikawa

❮ Previous
Next ❯

Citations

Jul 23, 1991·European Journal of Pharmacology·W K MacNaughton, D G Gall
Jun 11, 1993·Neuroscience Letters·Z G JiangG Feuerstein
Apr 24, 2004·Biochemical Pharmacology·Nina Doroshenko, Petro Doroshenko
May 31, 2007·Proceedings of the National Academy of Sciences of the United States of America·Michael J BrunoOlaf S Andersen
Oct 1, 1994·The Journal of General Physiology·J A Lundbaek, O S Andersen
Nov 27, 2009·Journal of the Royal Society, Interface·Jens A LundbaekOlaf S Andersen
Feb 1, 1992·American Journal of Respiratory Cell and Molecular Biology·R D RievesJ H Shelhamer
Mar 1, 2003·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Ayumi HiranoMasao Sugawara
Dec 29, 2011·Frontiers in Bioscience (Landmark Edition)·Trevor J Shuttleworth
Jun 14, 2003·Leukemia & Lymphoma·Yves DenizotFranck Trimoreau
Sep 1, 1993·Experimental Lung Research·J A HotchkissJ R Harkema
Dec 7, 1991·Journal of Theoretical Biology·J A Dani, J A Fox
Jun 12, 2013·Biophysical Journal·Jose L AlejoOlaf S Andersen
Mar 13, 2009·Cell Calcium·Trevor J Shuttleworth
Nov 10, 2015·PloS One·Nicole B Ramsey, Olaf S Andersen
Jul 21, 1998·Molecular Reproduction and Development·S Soubeyrand, P Manjunath
Apr 3, 1999·Stroke; a Journal of Cerebral Circulation·E UhlL Schürer
Oct 1, 1990·Stroke; a Journal of Cerebral Circulation·P J LindsbergG Feuerstein
Aug 1, 1992·Stroke; a Journal of Cerebral Circulation·K SatohS Mizuno
May 1, 1995·Medicinal Research Reviews·W J HoulihanS H Cheon
Jul 1, 1992·Journal of Cellular Physiology·A Ahmed, S K Smith
Aug 1, 1991·Annals of Neurology·P J LindsbergG Feuerstein
Jan 11, 2003·The Journal of Biological Chemistry·Olivier MignenTrevor J Shuttleworth
Jun 1, 1993·Developmental Medicine and Child Neurology·A Leviton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.